Apellis(APLS)盘前涨超142% Biogen(BIIB)将以56亿美元收购该公司

Like
Comment
Favorite

Apellis(APLS)盘前涨超142% Biogen(BIIB)将以56亿美元收购该公司

金吾财讯03-31

金吾财讯| Apellis Pharmaceuticals(APLS)盘前涨超142%，每股报41.05美元。

消息面上，Biogen Inc.已同意以56亿美元收购Apellis Pharmaceuticals Inc.，扩大其在免疫学和罕见病领域的治疗能力，这是该公司有史以来规模最大的收购之一。该公司将以每股41美元的价格收购Apellis，是后者周一收盘价的两倍多。通过这笔交易，Biogen将获得两种已获批准的药物。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

No comments yet

Most Discussed

7x24

All

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/2623858686?lang=en_US&edition=fundamental","thumbnail":"https://static.szfiu.com/news/20250107/ZWE1ODViOTJlYWU0Yzg0YTU1MDJhZDdhZjY5ZjlmNDM0MDU5MzAwNzIw.png","is_english":false,"pubTime":"2026-03-31 19:31","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2623858686","market":"us","top_or_hot":-1,"title":"Apellis(APLS)盘前涨超142% Biogen(BIIB)将以56亿美元收购该公司","media":"金吾财讯","content":"<html><body><p>金吾财讯| Apellis Pharmaceuticals(APLS)盘前涨超142%，每股报41.05美元。</p><p>消息面上，Biogen Inc.已同意以56亿美元收购<a href=\"https://laohu8.com/S/APLS\">Apellis Pharmaceuticals Inc.</a>，扩大其在免疫学和罕见病领域的治疗能力，这是该公司有史以来规模最大的收购之一。该公司将以每股41美元的价格收购Apellis，是后者周一收盘价的两倍多。通过这笔交易，Biogen将获得两种已获批准的药物。</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apellis(APLS)盘前涨超142% Biogen(BIIB)将以56亿美元收购该公司</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApellis(APLS)盘前涨超142% Biogen(BIIB)将以56亿美元收购该公司\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086022552\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/19a93586c3b023ec6ebfed568990555c);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">金吾财讯 </p>\n<p class=\"h-time\">2026-03-31 19:31</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>金吾财讯| Apellis Pharmaceuticals(APLS)盘前涨超142%，每股报41.05美元。</p><p>消息面上，Biogen Inc.已同意以56亿美元收购<a href=\"https://laohu8.com/S/APLS\">Apellis Pharmaceuticals Inc.</a>，扩大其在免疫学和罕见病领域的治疗能力，这是该公司有史以来规模最大的收购之一。该公司将以每股41美元的价格收购Apellis，是后者周一收盘价的两倍多。通过这笔交易，Biogen将获得两种已获批准的药物。</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4533","symbol_name":"AQR资本管理(全球第二大对冲基金)","start_time":0,"source_url":"298590","article_id":"2623858686","we_media_id":"1086022552","thumbnails":["https://static.szfiu.com/news/20250107/ZWE1ODViOTJlYWU0Yzg0YTU1MDJhZDdhZjY5ZjlmNDM0MDU5MzAwNzIw.png"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2623858686","pubTimestamp":1774956713,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"金吾财讯","introduction":"「金吾财讯」以精准用户需求为切入点，打造一站式港美股投资细分领域品牌。依托战略合作伙伴凤凰网财经，将港美股内容传播到全球华人圈。","home_visible":1,"id":"1086022552","head_image":"https://static.tigerbbs.com/19a93586c3b023ec6ebfed568990555c"},"summary":"金吾财讯| Apellis Pharmaceuticals(APLS)盘前涨超142%，每股报41.05美元。消息面上，Biogen Inc.已同意以56亿美元收购Apellis Pharmaceuticals Inc.，扩大其在免疫学和罕见病领域的治疗能力，这是该公司有史以来规模最大的收购之一。该公司将以每股41美元的价格收购Apellis，是后者周一收盘价的两倍多。通过这笔交易，Biogen将获得两种已获批准的药物。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4533":"AQR资本管理(全球第二大对冲基金)","BK4585":"ETF&股票定投概念","BK4505":"高瓴资本持仓","LU0320765992.SGD":"FTIF - Franklin Biotechnology Discovery A Acc SGD","LU0889565916.HKD":"FRANKLIN BIOTECHNOLOGY DISCOVERY \"A\" (HKD) ACC","LU0234570918.USD":"高盛全球核心股票组合Acc Close","APLS":"Apellis Pharmaceuticals Inc.","BK4139":"生物科技","LU1093756168.USD":"FRANKLIN K2 ALTERNATIVE STRATEGIES \"A\" (USD) ACC","BIIB":"渤健公司","BK4532":"文艺复兴科技持仓","IE00B894F039.SGD":"Legg Mason ClearBridge - US Aggressive Growth A Acc SGD-H","LU1093756325.SGD":"FTIF - Franklin K2 Alt Strat Fd A (acc) SGD-H1","BLLB":"Bell Buckle Holdings, Inc.","IE00B19Z9Z06.USD":"Legg Mason ClearBridge - US Aggressive Growth A Acc USD","LU0109394709.USD":"富兰克林生物科技新领域基金A (acc)","BK4588":"碎股","IE00B19Z9P08.USD":"LEGG MASON CLEARBRIDGE US AGGRESSIVE GROWTH \"A\" (USD) INC"},"translate_title":"Apellis (APLS) Gains Over 142% Premarket Biogen (BIIB) to Buy the Company for $5.6 Billion","themeId":"b2495f52240e7e9378faffff6c56a404","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"APLS":1.5,"BLLB":0.9,"BIIB":1.5},"content_text":"金吾财讯| Apellis Pharmaceuticals(APLS)盘前涨超142%，每股报41.05美元。消息面上，Biogen Inc.已同意以56亿美元收购Apellis Pharmaceuticals Inc.，扩大其在免疫学和罕见病领域的治疗能力，这是该公司有史以来规模最大的收购之一。该公司将以每股41美元的价格收购Apellis，是后者周一收盘价的两倍多。通过这笔交易，Biogen将获得两种已获批准的药物。","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"hasMoreComments":false,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"isCrawlerRequest":true}